Fit-For-All iPSC-Derived Cell Therapies and Their Evaluation in Humanized Mice With NK Cell Immunity
Human induced pluripotent stem cells (iPSCs) can be limitlessly expanded and differentiated into almost all cell types. Moreover, they are amenable to gene manipulation and, because they are established from somatic cells, can be established from essentially any person. Based on these characteristic...
Main Authors: | Charlotte Flahou, Tatsuya Morishima, Hitoshi Takizawa, Naoshi Sugimoto |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.662360/full |
Similar Items
-
Developing Humanized Animal Models with Transplantable Human iPSC-Derived Cells
by: Min Ma, et al.
Published: (2024-01-01) -
iPSC-derived cells for whole liver bioengineering
by: Kayque Alves Telles-Silva, et al.
Published: (2024-02-01) -
Role of Cytokines and Growth Factors in the Manufacturing of iPSC-Derived Allogeneic Cell Therapy Products
by: Chen-Yuan Kao, et al.
Published: (2023-05-01) -
IPSC-derived CAR-NK cells for cancer immunotherapy
by: Xiaotong Lin, et al.
Published: (2023-09-01) -
Murine models to study human NK cells in human solid tumors
by: Monica Parodi, et al.
Published: (2023-06-01)